Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
04 2021
Historique:
received: 04 07 2020
accepted: 06 07 2020
pubmed: 21 7 2020
medline: 16 10 2021
entrez: 21 7 2020
Statut: ppublish

Résumé

Standardized pathologic reporting for cancers improves patient care and prognostic determination. However, access in many countries is limited. To address this issue, the International Collaboration on Cancer Reporting (ICCR), a not-for-profit organization, has the mission to develop and disseminate standardized data sets for global use. Within endocrine organs, the parathyroid gland has rarely been included in formal pathologic data sets. Utilizing an expert international panel of eleven members, an evidence-based data set was developed for parathyroid carcinoma and atypical parathyroid neoplasms. This data set consists of sixteen core (required) elements viewed as essential for documentation of these conditions. Characterizing parathyroid carcinomas and atypical neoplasms begins with correlative clinical information, the operative procedure, specimens submitted, and site of the disease. The pathologic features essential to document include parathyroid weight, size, classification, and, when a carcinoma, the tumor grade. Histologic grade of parathyroid carcinoma incorporates other core elements including necrosis, mitotic count, perineural invasion, and lymphovascular invasion. Documenting the extent of disease locally into adjacent organs, regionally, and distally is critical for staging. Pathologic staging is now included as part of the American Joint Committee on Cancer 8th edition and is included in this data set. Ancillary studies should be recorded when performed as noncore elements. Standardized pathologic data sets for endocrine organs including the parathyroid gland are now available through the ICCR website. These essential resources enhance international standardization for documenting these rare tumors for both patient care and future guidelines.

Identifiants

pubmed: 32687943
pii: S0046-8177(20)30131-3
doi: 10.1016/j.humpath.2020.07.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-82

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Michelle D Williams (MD)

Department of Pathology in the Division of Pathology Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Electronic address: MDWillia@mdanderson.org.

Ron A DeLellis (RA)

Department of Pathology and Laboratory Medicine, Rhode Island Hospital and the Miriam Hospital, Providence, RI, 02906, USA.

Lori A Erickson (LA)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.

Ruta Gupta (R)

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, 2050, Australia; Central Clinical School, The University of Sydney, Sydney, 2006, Australia.

Sarah J Johnson (SJ)

Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne, NE1 4LP, UK.

Kaori Kameyama (K)

Department of Pathology, Showa University Northern Yokohama Hospital, Yokohama, 224-8503, Japan.

Sonali Natu (S)

Department of Pathology, University Hospital of North Tees and Hartlepool, Stockton, TS198PE, UK.

Tony Ng (T)

Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, V6T 1Z4, Canada.

Aurel Perren (A)

Institute of Pathology, University of Bern, Bern, 3008, Switzerland.

Nancy D Perrier (ND)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Raja R Seethala (RR)

Department of Pathology, University of Pittsburgh, Pittsburgh, PA, 15213, USA.

Anthony J Gill (AJ)

University of Sydney, Sydney, New South Wales, 2006, Australia; Cancer Diagnosis and Pathology Group Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH